DEXAMETHASONE SODIUM PHOSPHATE

Pre-Launch

dexamethasone sodium phosphate

Thayer Medical
ANDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
2

Indications (11)

Rheumatoid arthritispsoriasisasthmaAtopic dermatitisUlcerative colitismultiple sclerosisanemiaLeukemialymphomaof severeincapacitating allergic conditions intractable to adequate trials of conventional treatment in: Bronchial asthma

Clinical Trials (2)

NCT02770807Phase 3Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients

Started Mar 2017
NCT01255358Phase 2Completed

Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients

Started Feb 2011
Company
TM
Thayer Medical
AZ - Tucson
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers